Live, attentuated respiratory syncytial virus
The present invention features live, attenuated respiratory syncytial viruses (RSV) useful as vaccines against RSV infection and/or the development of severe RSV-associated illnesses. The disclosed viruses are attenuated to the extent of being nonpathogenic when administered to a subject but substan...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
19.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!